Western Wealth Management »

Pharmacyte Biotech shares owned by Western Wealth Management

Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by Western Wealth Management from 13F filings

Historical chart of Western Wealth Management investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by Western Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by Western Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $8 13 0.69

More positions owned by Western Wealth Management

Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Spdr Series Trust State Street Spd (SPYG)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)

View all positions for Western Wealth Management

Top funds holding Pharmacyte Biotech

Citadel Advisors
Geode Capital Management
Sabby Management
Renaissance Technologies
Vanguard Group
Vanguard Capital Management
Northern Trust
Schonfeld Strategic Advisors
Simplex Trading
Hrt Financial
XTX Topco
Vanguard Fiduciary Trust
Equitec Proprietary Markets
Two Sigma Securities
Jane Street

View all funds holding Pharmacyte Biotech